LEBWOHL, M. G.; SUGARMAN, J.; PARISER, D. M.; BAGEL, J.; TRICKETT, C.; JACOBSON, A.; ISRAEL, R. Safety and Tolerability of Fixed Combination Halobetasol Propionate 0.01% and Tazarotene 0.045% (HP/TAZ) Lotion in Patients With Moderate-to-Severe Plaque Psoriasis: Results From a 1-Year, Open-Label Study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 4, n. 5, p. s38, 2020. DOI: 10.25251/skin.4.supp.38. Disponível em: https://www.jofskin.org/index.php/skin/article/view/987. Acesso em: 5 jul. 2022.